These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18412288)

  • 21. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.
    Misra S; Hascall VC; Berger FG; Markwald RR; Ghatak S
    Connect Tissue Res; 2008; 49(3):219-24. PubMed ID: 18661347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronic acid as a potential boron carrier for BNCT: Preliminary evaluation.
    Zaboronok A; Yamamoto T; Nakai K; Yoshida F; Uspenskii S; Selyanin M; Zelenetskii A; Matsumura A
    Appl Radiat Isot; 2015 Dec; 106():181-4. PubMed ID: 26302663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
    de la Fuente M; Seijo B; Alonso MJ
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2016-24. PubMed ID: 18436835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and NMR characterization of new hyaluronan-based NO donors.
    Di Meo C; Capitani D; Mannina L; Brancaleoni E; Galesso D; De Luca G; Crescenzi V
    Biomacromolecules; 2006 Apr; 7(4):1253-60. PubMed ID: 16602746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
    Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient synthesis of an aldehyde functionalized hyaluronic acid and its application in the preparation of hyaluronan-lipid conjugates.
    Ruhela D; Riviere K; Szoka FC
    Bioconjug Chem; 2006; 17(5):1360-3. PubMed ID: 16984148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronan-CD44 pathway regulates orientation of mitotic spindle in normal epithelial cells.
    Fujiwara T; Kawakatsu T; Tayama S; Kobayashi Y; Sugiura N; Kimata K; Takai Y
    Genes Cells; 2008 Jul; 13(7):759-70. PubMed ID: 18513329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronan substratum induces multidrug resistance in human mesenchymal stem cells via CD44 signaling.
    Liu CM; Chang CH; Yu CH; Hsu CC; Huang LL
    Cell Tissue Res; 2009 Jun; 336(3):465-75. PubMed ID: 19350274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity.
    Lee H; Lee K; Park TG
    Bioconjug Chem; 2008 Jun; 19(6):1319-25. PubMed ID: 18481885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of hyaluronan polyaldehyde-a precursor of biopolymer conjugates.
    Šedová P; Buffa R; Kettou S; Huerta-Angeles G; Hermannová M; Leierová V; Šmejkalová D; Moravcová M; Velebný V
    Carbohydr Res; 2013 Apr; 371():8-15. PubMed ID: 23454201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers.
    He Y; Wu GD; Sadahiro T; Noh SI; Wang H; Talavera D; Wang H; Vierling JM; Klein AS
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G305-12. PubMed ID: 18556418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of hyaluronan-CD44 interactions in inflammation and tumorigenesis.
    Heldin P; Karousou E; Bernert B; Porsch H; Nishitsuka K; Skandalis SS
    Connect Tissue Res; 2008; 49(3):215-8. PubMed ID: 18661346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells.
    Sugahara KN; Hirata T; Tanaka T; Ogino S; Takeda M; Terasawa H; Shimada I; Tamura J; ten Dam GB; van Kuppevelt TH; Miyasaka M
    Cancer Res; 2008 Sep; 68(17):7191-9. PubMed ID: 18757435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of HA-PEG-PCL intelligent core-corona nanoparticles for delivery of doxorubicin.
    Yadav AK; Mishra P; Jain S; Mishra P; Mishra AK; Agrawal GP
    J Drug Target; 2008 Jul; 16(6):464-78. PubMed ID: 18604659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer.
    Ghatak S; Hascall VC; Berger FG; Penas MM; Davis C; Jabari E; He X; Norris JS; Dang Y; Markwald RR; Misra S
    Connect Tissue Res; 2008; 49(3):265-9. PubMed ID: 18661357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and cellular uptake of fluorescently labeled multivalent hyaluronan disaccharide conjugates of oligonucleotide phosphorothioates.
    Karskela M; Virta P; Malinen M; Urtti A; Lönnberg H
    Bioconjug Chem; 2008 Dec; 19(12):2549-58. PubMed ID: 19053300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
    He M; Zhao Z; Yin L; Tang C; Yin C
    Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 6-O-methotrexylhyaluronan as a drug delivery system.
    Sorbi C; Bergamin M; Bosi S; Dinon F; Aroulmoji V; Khan R; Murano E; Norbedo S
    Carbohydr Res; 2009 Jan; 344(1):91-7. PubMed ID: 18926524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.